Evidence that the protein phosphatase activity of PTEN contributes to embryonic development and tumour suppression in mice

This study demonstrates that the protein phosphatase activity of PTEN, distinct from its lipid phosphatase function, is essential for normal embryonic development and tumor suppression in mice, as evidenced by the embryonic lethality and increased tumorigenesis observed in mice expressing a mutant PTEN lacking protein phosphatase activity.

The Gist

Imagine your body is a bustling city. In this city, there is a very important traffic cop named PTEN. His main job is to keep the flow of traffic (cell growth and division) under control so the city doesn't get chaotic and turn into a traffic jam (cancer).

For a long time, scientists thought PTEN had only one specific tool in his belt: a lipid phosphatase. You can think of this tool like a "stop sign" that he holds up to a specific type of car (a molecule called PIP3) to tell it to slow down. If PTEN loses this tool, the PIP3 cars speed off, the traffic lights turn green everywhere, and the city spirals into chaos, leading to tumors.

But this new paper asks a big question: Is that stop sign the only tool PTEN needs? Or does he have a second, hidden tool—a protein phosphatase—that helps him do his job even better?

Here is the story of how they found out, explained simply:

1. The Experiment: Building a "One-Tool" Cop

The scientists decided to build a special version of PTEN (called PTEN-Y138L) that still had his original "stop sign" tool (lipid phosphatase) but had lost his second, hidden tool (protein phosphatase).

Think of it like taking a Swiss Army knife and removing the screwdriver, but keeping the knife blade. The blade still works, but maybe the screwdriver was needed for something else important.

2. The Baby City: Embryonic Development

First, they tried to make mice that had two copies of this "one-tool" PTEN (homozygous).

• The Result: The baby mice (embryos) didn't survive. They stopped growing very early, around day 9 or 10 of pregnancy.
• The Analogy: It's like trying to build a house with a hammer but no nails. You can hit things (the lipid tool works), but you can't actually hold the structure together. The "protein tool" was essential for the very basic construction of life. Without it, the city couldn't even get built.

3. The Adult City: Tumors and Survival

Next, they looked at mice that had one normal PTEN and one "one-tool" PTEN (heterozygous). This is like having one full Swiss Army knife and one that's missing the screwdriver.

• The Result: These mice lived significantly shorter lives than mice with two full knives. They developed tumors in many different places: the gut, lymph nodes, ovaries, and prostate.
• The Comparison: They also compared them to mice that had less of the normal PTEN protein (but it was the full, correct version). Surprisingly, the mice with the "one-tool" PTEN got sick faster and had more tumors than the mice with just "less" PTEN.
• The Lesson: It wasn't just that there was less PTEN; it was that the PTEN they did have was broken in a specific way. The missing "protein tool" made the whole system less effective at stopping cancer.

4. The T-Cell Test: A Specific Case

The scientists also looked at a specific type of cancer called T-cell leukemia. They knew that in this specific case, the "stop sign" tool (lipid phosphatase) was the most important thing.

• The Result: Even with the "one-tool" PTEN, the mice didn't get T-cell leukemia.
• The Analogy: This is like a specific type of traffic jam that only happens if the stop sign is missing. Since the "one-tool" PTEN still had the stop sign, it could still fix this specific problem. But for the general chaos of other cancers and for building the body, the missing screwdriver (protein tool) mattered a lot.

The Big Takeaway

For years, we thought PTEN was like a single-tool security guard who just stopped one type of car. This paper shows that PTEN is actually a multi-tool security guard.

• The Lipid Tool (Stop Sign): Essential for stopping the main cancer signal (PI3K pathway).
• The Protein Tool (Screwdriver): Essential for the fine-tuning of the system, for building the body correctly during pregnancy, and for preventing a wide variety of tumors.

In simple terms: You can't just have half a PTEN. If you take away its ability to work on proteins, even if it can still work on lipids, the body's construction fails, and the city (the body) becomes much more vulnerable to crime (cancer). This suggests that future cancer treatments need to understand that PTEN is doing two different jobs, and we might need to target both to save the city.

Technical Summary

1. The Problem

PTEN (Phosphatase and Tensin Homologue) is a critical tumor suppressor frequently mutated in human cancers. Its primary known mechanism is lipid phosphatase activity, where it dephosphorylates PIP3 (phosphatidylinositol (3,4,5)-trisphosphate) to PIP2, thereby inhibiting the oncogenic PI3K/AKT signaling pathway.

However, PTEN also possesses protein phosphatase activity in vitro, capable of dephosphorylating protein substrates and auto-dephosphorylating its own C-terminal tail (specifically at Thr366). While in vitro studies and cell culture models suggested this activity might regulate cell invasion and morphology, its physiological significance in vivo remained unclear. Previous mouse models (e.g., Pten null or lipid-phosphatase-dead Pten^G129E) confirmed the lipid activity's role in tumor suppression, but the specific contribution of the protein phosphatase activity to embryonic development and spontaneous tumorigenesis had not been definitively established in a whole-organism context.

2. Methodology

The authors employed a genetic knock-in approach to generate a mouse model expressing a specific PTEN mutant: PTEN-Y138L.

• The Mutant (PTEN-Y138L): This mutation selectively abolishes protein phosphatase activity while retaining full lipid phosphatase activity (PIP3 dephosphorylation).
• Generation of Mice: Germline knock-in mice (Pten^Y138L) were created on a C57BL/6J background.
• Experimental Groups:
  • Homozygous (Pten^Y138L/Y138L): To assess embryonic viability.
  • Heterozygous (Pten^+/Y138L): To assess spontaneous tumor development and survival compared to Wild Type (Pten^+/+), Null heterozygous (Pten^+/-), and Hypomorphic (Pten^+/Hyp) controls.
  • T-cell Specific Deletion: To isolate the role of protein phosphatase activity in T-cell lymphomagenesis, the authors crossed Pten^Y138L mice with Lck-Cre mice and Pten^Flox mice. This generated mice where T-cells expressed only the Pten^Y138L allele (Pten^Flox/Y138L Lck-Cre), compared to controls lacking PTEN entirely (Pten^Flox/Flox Lck-Cre).
• Assays:
  • In Vitro: Lentiviral expression of PTEN variants in cancer cell lines (U87-MG, MDA-MB-468, HCT116) to measure AKT phosphorylation and PI3K pathway components.
  • In Vivo: Long-term survival studies (up to 700 days), post-mortem histopathological analysis of tumors, and embryonic staging (E8.5–E10.5) for homozygous mutants.
  • Biochemical: Immunoblotting for PTEN stability and AKT phosphorylation; Mass spectrometry for PIP3 levels in thymocytes.

3. Key Contributions

• First In Vivo Model for Protein Phosphatase Activity: This study provides the first definitive genetic evidence using a knock-in mouse model to isolate the protein phosphatase function of PTEN from its lipid phosphatase function.
• Decoupling Lipid vs. Protein Functions: By using the Y138L mutant, the authors demonstrated that retaining lipid activity alone is insufficient for normal embryonic development and full tumor suppression, challenging the dogma that lipid phosphatase activity is the sole driver of PTEN's tumor suppressor function.
• T-Cell Specificity: The study clarifies that T-cell lymphomagenesis is strictly dependent on the lipid phosphatase activity (PIP3 regulation), whereas other tumor types and developmental processes require the protein phosphatase activity.

4. Results

A. PTEN-Y138L Retains Lipid Activity In Vitro

In cultured cancer cells, expression of PTEN-Y138L reduced AKT phosphorylation and downstream signaling (FOXO1, PRAS40, S6) with the same efficiency as Wild-Type PTEN. This confirmed that the mutant effectively suppresses the PI3K pathway via its lipid phosphatase activity.

B. Embryonic Lethality of Homozygous Mutants

• Finding: No homozygous Pten^Y138L/Y138L mice were born from heterozygous crosses.
• Developmental Defect: Homozygous embryos died in utero before embryonic day 10.5 (E10.5).
• Morphology: At E8.5, homozygous embryos lacked anterior neural folds and were smaller. By E9.5, they failed to undergo embryonic turning. By E10.5, they were reabsorbed.
• Conclusion: The protein phosphatase activity of PTEN is essential for normal mouse embryonic development.

C. Reduced Survival and Tumorigenesis in Heterozygotes

• Survival: Heterozygous Pten^+/Y138L mice had significantly reduced overall survival compared to Wild Type, though they survived longer than Pten^+/- (null) mice.
• Tumor Spectrum: Pten^+/Y138L mice developed a broad spectrum of spontaneous tumors similar to Pten^+/- mice, including:
  • B-cell lymphomas (mesenteric and peripheral).
  • Gastrointestinal polyps and masses.
  • Endometrial hyperplasia and mammary carcinoma (females).
  • Prostate carcinoma (males).
  • Adrenal pheochromocytomas.
• Significance: Despite having functional lipid phosphatase activity, the loss of protein phosphatase activity in Pten^+/Y138L mice was sufficient to drive tumorigenesis across multiple organs, proving this activity is required for tumor suppression in vivo.

D. T-Cell Lymphoma is Independent of Protein Phosphatase Activity

• Experiment: Mice with T-cells expressing only PTEN-Y138L (Pten^Flox/Y138L Lck-Cre) were monitored.
• Result: These mice did not develop T-cell lymphomas and had normal PIP3 levels and AKT phosphorylation in thymocytes.
• Contrast: Mice with T-cells completely lacking PTEN (Pten^Flox/Flox Lck-Cre) developed aggressive T-cell lymphomas rapidly.
• Conclusion: T-cell lymphomagenesis is driven strictly by the loss of lipid phosphatase activity (PIP3 accumulation). The protein phosphatase activity is dispensable for preventing T-cell lymphomas.

5. Significance

This study fundamentally refines the understanding of PTEN's tumor suppressor mechanism:

1. Dual Requirement: Full tumor suppression and embryonic development require both lipid and protein phosphatase activities. The lipid activity controls the PI3K/AKT axis, while the protein activity (potentially involving auto-dephosphorylation of Thr366 or dephosphorylation of other substrates) is critical for developmental processes and preventing specific non-T-cell tumors.
2. Mechanistic Insight: The data suggests that the protein phosphatase activity may be linked to DNA damage repair or the coordination of localized PIP3 pools, as suggested by previous literature, though the exact substrates remain to be fully defined.
3. Clinical Relevance: The findings highlight that therapeutic strategies targeting PTEN-deficient cancers must consider that restoring only lipid phosphatase activity (or mimicking it) may not be sufficient to prevent all forms of tumorigenesis or correct developmental defects. It underscores the complexity of PTEN regulation and the potential need for therapies that address its multifaceted roles.